Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol for Right Ventricular Dysfunction in PAH
NCT02507011Phase 2Terminated
- Sponsor
- University of Minnesota
- Start
- Jan 2016
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carvedilol in pulmonary arterial hypertension (PAH), sponsored by University of Minnesota. Started Jan 2016; status: terminated.
02
Drugs
carvedilol
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT02507011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02507011.